Ilan Neugarten joined the Viola Group in 2000 as a partner
of DOR Ventures, a VC fund focusing on imaging technologies. During his period
at DOR Ventures he led various investments including medical imaging
Prior to DOR Ventures, Ilan spent 20 years at Scitex holding a variety of
positions. From 1998 to 2000, he was General Manager of the Print On-Demand
Solutions Division and led a major turn around, making the division profitable
within six months and signing a multi-million dollar OEM agreement. From 1992
to 1998, he was General Manager of Scitex Japan KK and a board member of Nihon
Scitex Ltd. He led growth from $30 million in revenue to $105 million and
concluded the largest Scitex OEM sale, valued at $55 million (to NTT). As part
of his tenure in Scitex and Dor Ventures, Ilan has gained considerable
experience in the medical device industry.
Following his success in making investments in medical
imaging companies, Ilan currently manages the Viola Group medical device
investment program. In this capacity he identifies and leads investments in
early stage Israeli medical device companies. He then assists these companies
through their development and growth stage as an active board member.
Ilan received his BSc in electronics from the Technion and MBA from Boston University.